Provided By GlobeNewswire
Last update: Aug 28, 2025
TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in the Lake Street Capital Markets “BIG9” Conference on September 11, 2025 in New York City.
Read more at globenewswire.comNASDAQ:PROF (9/3/2025, 4:10:09 PM)
4.36
-0.14 (-3.11%)
Find more stocks in the Stock Screener